Abstract
Objective
Disorders of glucose metabolism in children with obesity are less common than in adults. There is also evidence that they may be transient. The aims of this study were to determine the prevalences of impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and type 2 diabetes mellitus (DM2) and its reversibility in pediatric patients with obesity and to define the factors determining the reversibility of prediabetes or progression to diabetes.
Methods
Retrospective analysis included of young patients with obesity. Patients presented and were treated between 2000-2022 at a single center.
Results
The study included 573 (316 girls; 55.15%) Caucasian patients with median body mass index (BMI) Z-score of 3.95 (range 2.0-9.9) and median age 13.9 (2.9-17.1) years old. OGTT results were normal in 90.8% (n=520) and signs of prediabetes occurred in 9.2% (n=53); IFG 17%, IGT 88.7%, DM 0%. Among those who underwent OGTT twice (n=53), impaired glucose regulation was present in 9.3% (n=5) (IFG 40%, IGT 80%, DM 0%) at baseline and in 14.8% subject (n=8) (IFG 25%, IGT 50%, DM 25%) at follow-up after lifestyle modification only. After 12-36 months of follow up, in those with a history of IGT, 60% reverted to normal glucose tolerance, while IFG and IGT persisted in 20% and 20%, respectively, and none progressed to DM. The risk factors for progression of glucose metabolism disorders were increase of BMI Z-score, higher insulin levels and elevated homeostatic model assessment-insulin resistance.
Conclusion
IFG and IGT are common in pediatric patients with obesity, while the progression to DM2 is rare. Disorders of glucose metabolism have reversible character.
Keywords: Childhood obesity, glucose metabolism, type 2 diabetes
Read the full text
5 sections · 1 figure · 2 tables · PDF
Create your free account to read the full text.
- Full text with figures and tables
- PDF and supplementary files
- Access on every Galenos journal
One Galenos account works on every Galenos journal site.
References
WHO European Regional Obesity Report 2022. Copenhagen: WHO Regional Office for Europe; 2022. Licence: CC BY-NC-SA 3.0 IGO. Available from:https://www.who.int/europe/publications/i/item/9789289057738
Pawel B, Chomiuk T, Gałązka-Sobotka M. Zalecenia kliniczne dotyczące postępowania u chorych na otyłość 2022 - stanowisko Polskiego Towarzystwa Leczenia Otyłości. Med Prakt. 2022:1-87.
Skelton JA, Klish WJ. Overview of the health consequences of obesity in children and adolescents. UpToDate. 2023.
Wu J, Ward E, Threatt T, Lu ZK. Progression to Type 2 Diabetes and Its Effect on Health Care Costs in Low-Income and Insured Patients with Prediabetes: A Retrospective Study Using Medicaid Claims Data. J Manag Care Spec Pharm. 2017;23:309-316.
D’Adamo E, Caprio S. Type 2 diabetes in youth: epidemiology and pathophysiology. Diabetes Care. 2011;34(Suppl 2):161-165.
Weiss R, Santora N, Giannini C, Galderisi A, Umano GR. Prediabetes in youths: mechanisms and biomarkers. Lancet Child Adolesc. 2017;1:240-248.
Weir CB, Jan A. BMI Classification Percentile And Cut Off Points. StatPearls Publishing, 2022.
Álvarez J, Aguilar F, Lurbe E. Blood pressure measurement in children and adolescents: key element in the evaluation of arterial hypertension. An Pediatr (Engl Ed). 2022;96:536. Epub 2022 Jun 1
Czupryniak L. Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2022 Stanowisko Polskiego Towarzystwa Diabetologicznego. Current Topics in Diabetes. 2022;2:1-134.
Wabitsch M, Hauner H, Hertrampf M, Muche R, Hay B, Mayer H, Kratzer W, Debatin KM, Heinze E. Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany. Int J Obes Relat Metab Disord. 2004;28:307-313.
Martos-Moreno GÁ, Martínez-Villanueva J, González-Leal R, Chowen JA, Argente J. Sex, puberty, and ethnicity have a strong influence on growth and metabolic comorbidities in children and adolescents with obesity: Report on 1300 patients (the Madrid Cohort). Pediatr Obes. 2019;14:e12565. Epub 2019 Aug 2
Galderisi A, Giannini C, Weiss R, Kim G, Shabanova V, Santoro N, Pierpont B, Savoye M, Caprio S. Trajectories of changes in glucose tolerance in a multiethnic cohort of obese youths: an observational prospective analysis. Lancet Child Adolesc Health. 2018;2:726-735. Epub 2018 Aug 24
Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care. 2005;28:902-909.
Numbenjapon N, Nakavachara P, Santiprabhob J, Kiattisakthavee P, Wongarn R, Likitmaskul S. Successful strategy to improve glucose tolerance in Thai obese youth. J Med Assoc Thai. 2010;93(Suppl 6):131-138.
Perreault L, Kahn SE, Christophi CA, Knowler WC, Hamman RF; Diabetes Prevention Program Research Group. Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care. 2009;32:1583-1858. Epub 2009 Jul 8
Shibib L, Al-Qaisi M, Ahmed A, Miras AD, Nott D, Pelling M, Greenwald SE, Guess N. Reversal and Remission of T2DM - An Update for Practitioners. Vasc Health Risk Manag. 2022;18:417-443.
The Diabetes Prevention Program Research Group. The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group. Diabetes Care. 2000;23:1619-1629.
Libman IM, Barinas-Mitchell E, Bartucci A, Robertson R, Arslanian S. Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab. 2008;93:4231-4237. Epub 2008 Aug 19


